CorMedix Inc. (CRMD)

6.73
1.20 21.00
AMEX : Health Technology
Prev Close 5.56
Open 5.70
Day Low/High 5.59 / 6.94
52 Wk Low/High 4.20 / 13.70
Volume 681.24K
Avg Volume 252.00K
Exchange AMEX
Shares Outstanding 25.65M
Market Cap 131.33M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

CorMedix To Present At The Rodman & Renshaw Annual Global Investment Conference

CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it is...

CorMedix Reports Second Quarter 2010 Results

CorMedix Reports Second Quarter 2010 Results

CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced its ...

CorMedix Announces Appointment Of Key Positions

CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced the ...

CorMedix Statement On Today’s Market Activity

In view of the unusual market activity in the stock of CorMedix Inc.

CorMedix Added To Russell Microcap® Index

CorMedix Added To Russell Microcap® Index

CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that ...

CorMedix Doses First Patient In Phase II Clinical Trial Of CRMD-001

CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced dosing...

TheStreet Quant Rating: D+ (Sell)